Baylor Scott & White Heart and Vascular Hospital continues to be a leader in cardiovascular care through their involvement in innovative research to drive the future of cardiovascular medicine.
Published with Permission, Baylor Scott & White Health
Peter McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FNLA, FCRSA, medical director for Cardiovascular Research and Education – Baylor Scott & White Heart and Vascular Institute, presented a keynote address at the 17th Annual World Congress Insulin Resistance Diabetes and Cardiovascular Disease held in Las Angeles, CA. Dr. McCullough also represented Baylor Scott & White Heart and Vascular Hospital and Baylor University Medical Center as he presented Diabetes and the Cardiorenal Syndrome. His paper, "Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis and Treatment Strategies, A Scientific Statement from the American Heart Association," was published in the AHA's Circulation, and is an updated summary of new knowledge in the field of cardiorenal medicine and specifically addresses the issue of combined heart and kidney failure.
Many patients with advanced heart failure can be managed by a left ventricular assist device (LVAD). But there are some patients who are not candidates for an LVAD because they have biventricular failure. Baylor Dallas has been chosen as one of six clinical trial sites for the world’s most advanced total artificial heart. “No major changes have occurred in the field of total artificial heart in decades, so we are very excited to be able to offer access to participation in a clinical trial for this innovative pump to our patients who qualify,” says Dan M. Meyer, MD, surgical chief of heart transplant and mechanical circulatory support at Baylor Dallas. Tell me more.
Congratulations to Cara East, MD, FACP, FAPCR, on her new book titled Developing a Successful Clinical Research Program based on her experience leading the Soltero Cardiovascular Research. Beth Soltero hosted a book signing at the Soltero office on Oct. 19, 2018. Patients involved in some of her clinical trials, as well as fellow providers and family friends attended the event. Learn more about current clinical trials https://www.baylorhearthospital.com/clinicaltrials.
Paul Grayburn, MD, FACC, Medical Director, Non-Invasive Cardiology – Baylor Scott & White Heart and Vascular Hospital – Dallas; Medical Director, Cardiology Research and Education – Baylor University Medical Center, was recently appointed by the American College of Cardiology (ACC) as an associate editor for the Journal of the American College of Cardiology: Cardiovascular
Imaging. This prestigious appointment is the latest in Dr. Grayburn’s list of journal-related involvement as he is an associate editor for American Journal of Cardiology as well as Structural Heart: Journal of the Heart Team.
Dr. Grayburn has published more than 400 manuscripts or book chapters in peer-reviewed journals. He has served in leadership roles in several multicenter trials (BEST, STICH, EVEREST II, COAPT, CTSN, Apollo) and directs an echocardiographic core laboratory for clinical trials in valvular heart disease. Dr. Grayburn is also a Clinical Professor of Medicine at Texas A&M University.
PARADIGM-HF trial is shown to help reduce the rate of kidney function loss up to 50 percent more than conventional treatment in patients with diabetes. Milton Packer, MD, reviews the study and reports on results.
Baylor Scott & White Heart and Vascular Hospital is one of three Baylor Scott & White Health locations currently serving as a study site for system's participation in a landmark precision medicine study – the All of Us Research Program. All of Us is the largest study ever executed in the United States by the National Institutes of Health (NIH), with a goal of enrolling 1 million participants across the country.
Baylor Scott & White is currently the only healthcare provider in Texas enrolling participants in the study and will receive a total of $14 million in funding from NIH over five years. The system is collaborating through a consortium that includes Baylor Scott & White, Henry Ford Health System in Detroit, Essentia Health headquartered in Minnesota, Spectrum Health in Michigan and University of Massachusetts Medical School.
Dr. Packer won a national award in specialized journalism — the Jesse H. Neal Award — in the category of "Best Commentary/Blog." The Neal Awards are considered the "Pulitzer Prize" of the business press. Established in 1955, the Neal Awards strive to recognize journalists that "act as the conscience of the fields they serve."
March 20, 2017 – Baylor Scott & White Heart and Vascular Institute has executed a contract for a major research grant or nearly one-quarter of a million dollars under an investigator initiated original research submission to Amgen, Inc. The proposal prepared is titled, Therapeutic Intensity of Lipid Lowering Therapy on Recurrent Cardiovascular Events. The project will harness the power of the data infrastructure to evaluate the pharmaco-epidemiology of cholesterol lowering medications in patients with recurrent heart attacks. Stated Peter McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FNLA, who designed the study, "This is important work given the new genre of super-powerful cholesterol lowering agents that are given via injections but at high costs. Please join me in congratulating Kristen Tecson, PhD, who will lead this project. I want to recognize Puja Garg, PhD, and Anu Vasudevan, PhD, who have worked administratively during the award process and will be integral to the research team as this project moves forward." Baylor Scott & White Heart and Vascular Hospital team congratulates the entire research team on this announcement.
William C. Roberts, MD, honored by American College of Cardiology with a Lifetime Achievement Award, prestigious recognition from the American College of Cardiology on Monday, April 4, 2016, in Chicago.
For a listing of Dr. Roberts' books:
1. Roberts WC, editor in chief. From-the-Editor Columns Published in The American Journal of Cardiology 1982-2015. Dallas: Baylor Scott & White Health 2016:623.
2. Roberts WC, editor in chief, Interviews Published in The American Journal of Cardiology 1982 – 2015, Volume 1:A-K. Dallas: Baylor Scott & White Health 2016:684.
3. Roberts WC, editor in chief. Interviews Published in The American Journal of Cardiology 1982 – 2015, Volume 2: L-Z. Dallas: Baylor Scott & White Health 2016:571.
4. Roberts WC, interviewer and Editor. Collected Interviews of Baylor University Medical Center Physicians and Administrators Published in Baylor University Medical Center Proceedings 1995 – 2015, Dallas: Baylor Scott & White Health 2015:951.
5. Roberts WC, editor in chief. Facts and Ideas from Anywhere: From-the-Editor Columns Published in Baylor University Medical Center Proceedings 2011 – 2015, Dallas: Baylor Scott & White Health 2015:509.
6. Roberts WC, interviewer and editor. Collected Interviews of Some Visiting Professors
DALLAS December 3, 2015 – Baylor University Medical Center at Dallas announces the appointment of Milton Packer, MD, as the new Distinguished Scholar in Cardiovascular Science. Dr. Packer's recent study findings now published in latest New England Journal of Medicine.
read the release
Research Team Publishes Findings on New Heart Failure Drugs That Prolong Patient's Lives
Dr. Packer, Distinguished Scholar, can be reached through Baylor Heart and Vascular Institute at 214-820-7500
In addition to opening the first heart-specialty hospital in North Texas, Baylor Scott & White Heart and Vascular Hospital has paved the way in heart and vascular care with breakthrough techniques. Just look at these North Texas firsts at Baylor Scott & White Heart and Vascular Hospital: